{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,29]],"date-time":"2026-04-29T02:38:30Z","timestamp":1777430310633,"version":"3.51.4"},"reference-count":33,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Therapies"],"published-print":{"date-parts":[[2025,7]]},"DOI":"10.1016\/j.therap.2025.02.012","type":"journal-article","created":{"date-parts":[[2025,3,4]],"date-time":"2025-03-04T19:11:25Z","timestamp":1741115485000},"page":"424-428","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"title":["Impact d\u00e9l\u00e9t\u00e8re d\u2019un anti-inflammatoire non st\u00e9ro\u00efdien pris pour fi\u00e8vre ou douleur aigu\u00eb en cas d\u2019infection streptococcique"],"prefix":"10.1016","volume":"80","author":[{"given":"Annie-Pierre","family":"Jonville-Bera","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jo\u00eblle","family":"Micallef","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.therap.2025.02.012_bib0170","first-page":"1","article-title":"Over-the-counter non-steroidal anti-inflammatory medications: focus on the management of acute pain","author":"Burlacu","year":"2024","journal-title":"Therapie"},{"key":"10.1016\/j.therap.2025.02.012_bib0175","series-title":"Actualit\u00e9\u00a0\u2013\u00a0bon usage du parac\u00e9tamol et des anti-inflammatoires non st\u00e9ro\u00efdiens (AINS)\u00a0: ces m\u00e9dicaments ne pourront plus \u00eatre pr\u00e9sent\u00e9s en libre acc\u00e8s","year":"2021"},{"key":"10.1016\/j.therap.2025.02.012_bib0180","series-title":"PRAC recommendations on signal","year":"2020"},{"key":"10.1016\/j.therap.2025.02.012_bib0185","series-title":"\u00c9v\u00e8nement\u00a0\u2013\u00a0Comit\u00e9 scientifique permanent pharmacosurveillance et bon usage\u00a0\u2013\u00a0Formation restreinte expertise et bon usage","year":"2024"},{"key":"10.1016\/j.therap.2025.02.012_bib0190","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1007\/s00408-016-9973-1","article-title":"Non-steroidal anti-inflammatory drugs may worsen the course of community-acquired pneumonia: a cohort study","volume":"195","author":"Basille","year":"2017","journal-title":"Lung"},{"key":"10.1016\/j.therap.2025.02.012_bib0195","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1086\/338460","article-title":"An epidemiological investigation of a sustained high rate of pediatric parapneumonic empyema: risk factors and microbiological associations","volume":"34","author":"Byington","year":"2002","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.therap.2025.02.012_bib0200","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1002\/ppul.23041","article-title":"Risk factors for the development of pleural empyema in children","volume":"50","author":"Elemraid","year":"2015","journal-title":"Pediatr Pulmonol"},{"key":"10.1016\/j.therap.2025.02.012_bib0205","doi-asserted-by":"crossref","first-page":"861","DOI":"10.1111\/j.1651-2227.2010.01734.x","article-title":"Prevalence and risk factors of suppurative complications in children with pneumonia","volume":"99","author":"Fran\u00e7ois","year":"2010","journal-title":"Acta Paediatr"},{"key":"10.1016\/j.therap.2025.02.012_bib0210","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1016\/j.rmed.2016.12.005","article-title":"Prehospital NSAIDs use prolong hospitalization in patients with pleuro-pulmonary infection","volume":"123","author":"Kotsiou","year":"2017","journal-title":"Respir Med"},{"key":"10.1016\/j.therap.2025.02.012_bib0215","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1111\/crj.12524","article-title":"Risk factors for local complications in children with community-acquired pneumonia","volume":"12","author":"Krenke","year":"2018","journal-title":"Clin Respir J"},{"key":"10.1016\/j.therap.2025.02.012_bib0220","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/j.jpeds.2016.05.025","article-title":"Nonsteroidal anti-inflammatory drug without antibiotics for acute viral infection increases the empyema risk in children: a matched case-control study","volume":"175","author":"Le Bourgeois","year":"2016","journal-title":"J Pediatr"},{"key":"10.1016\/j.therap.2025.02.012_bib0225","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1016\/j.jcrc.2014.05.021","article-title":"Risks of nonsteroidal antiinflammatory drugs in undiagnosed intensive care unit pneumococcal pneumonia: younger and more severely affected patients","volume":"29","author":"Messika","year":"2014","journal-title":"J Crit Care"},{"key":"10.1016\/j.therap.2025.02.012_bib0230","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1378\/chest.09-3102","article-title":"Nonsteroidal antiinflammatory drugs may affect the presentation and course of community-acquired pneumonia","volume":"139","author":"Voiriot","year":"2011","journal-title":"Chest"},{"key":"10.1016\/j.therap.2025.02.012_bib0235","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1016\/S1047-2797(97)00040-9","article-title":"Ibuprofen and skin and soft tissue superinfections in children with varicella","volume":"7","author":"Choo","year":"1997","journal-title":"Ann Epidemiol"},{"key":"10.1016\/j.therap.2025.02.012_bib0240","doi-asserted-by":"crossref","first-page":"26","DOI":"10.2340\/00015555-0333","article-title":"Bacterial skin infections in children hospitalized with varicella: a possible negative impact of non-steroidal anti-inflammatory drugs?","volume":"88","author":"Dubos","year":"2008","journal-title":"Acta Derm Venereol"},{"key":"10.1016\/j.therap.2025.02.012_bib0245","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1111\/j.1365-2125.2007.02997.x","article-title":"Nonsteroidal anti-inflammatory drug use and the risk of severe skin and soft tissue complications in patients with varicella or zoster disease","volume":"65","author":"Mikaeloff","year":"2008","journal-title":"Br J Clin Pharmacol"},{"issue":"4\u00a0Pt 1","key":"10.1016\/j.therap.2025.02.012_bib0250","doi-asserted-by":"crossref","first-page":"783","DOI":"10.1542\/peds.103.4.783","article-title":"A case-control study of necrotizing fasciitis during primary varicella","volume":"103","author":"Zerr","year":"1999","journal-title":"Pediatrics"},{"key":"10.1016\/j.therap.2025.02.012_bib0255","doi-asserted-by":"crossref","first-page":"1062","DOI":"10.3201\/eid1107.040900","article-title":"Risk factors for pediatric invasive group A streptococcal disease","volume":"11","author":"Factor","year":"2005","journal-title":"Emerg Infect Dis"},{"key":"10.1016\/j.therap.2025.02.012_bib0260","doi-asserted-by":"crossref","first-page":"19110","DOI":"10.2807\/ese.14.05.19110-en","article-title":"Increase in invasive group A streptococcal infections in England, Wales and Northern Ireland, 2008-9","volume":"14","author":"Lamagni","year":"2009","journal-title":"Euro Surveill"},{"key":"10.1016\/j.therap.2025.02.012_bib0265","doi-asserted-by":"crossref","first-page":"R43","DOI":"10.1186\/cc7766","article-title":"A multicentre case-control study of nonsteroidal anti-inflammatory drugs as a risk factor for severe sepsis and septic shock","volume":"13","author":"Legras","year":"2009","journal-title":"Crit Care"},{"key":"10.1016\/j.therap.2025.02.012_bib0270","doi-asserted-by":"crossref","first-page":"1685","DOI":"10.1086\/504261","article-title":"Group A streptococcal myonecrosis: increased vimentin expression after skeletal-muscle injury mediates the binding of Streptococcus pyogenes","volume":"193","author":"Bryant","year":"2006","journal-title":"J Infect Dis"},{"key":"10.1016\/j.therap.2025.02.012_bib0275","doi-asserted-by":"crossref","first-page":"1692","DOI":"10.1086\/593016","article-title":"Muscle injury, vimentin expression, and nonsteroidal anti-inflammatory drugs predispose to cryptic group A streptococcal necrotizing infection","volume":"198","author":"Hamilton","year":"2008","journal-title":"J Infect Dis"},{"key":"10.1016\/j.therap.2025.02.012_bib0280","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1097\/QCO.0000000000000160","article-title":"The roles of injury and nonsteroidal anti-inflammatory drugs in the development and outcomes of severe group A streptococcal soft tissue infections","volume":"28","author":"Bryant","year":"2015","journal-title":"Curr Opin Infect Dis"},{"key":"10.1016\/j.therap.2025.02.012_bib0285","doi-asserted-by":"crossref","first-page":"e1010710","DOI":"10.1371\/journal.ppat.1010710","article-title":"SssP1, a Fimbria-like component of Streptococcus suis, binds to the vimentin of host cells and contributes to bacterial meningitis","volume":"18","author":"Pan","year":"2022","journal-title":"PLoS Pathog"},{"key":"10.1016\/j.therap.2025.02.012_bib0290","doi-asserted-by":"crossref","first-page":"e1010397","DOI":"10.1371\/journal.ppat.1010397","article-title":"Targeting the BspC-vimentin interaction to develop anti-virulence therapies during Group B streptococcal meningitis","volume":"18","author":"Manzer","year":"2022","journal-title":"PLoS Pathog"},{"issue":"8","key":"10.1016\/j.therap.2025.02.012_bib0295","doi-asserted-by":"crossref","first-page":"e1010765","DOI":"10.1371\/journal.ppat.1010765","article-title":"Streptococcal autolysin promotes dysfunction of swine tracheal epithelium by interacting with vimentin","volume":"18","author":"Meng","year":"2022","journal-title":"PLoS Pathog"},{"key":"10.1016\/j.therap.2025.02.012_bib0300","doi-asserted-by":"crossref","first-page":"21481","DOI":"10.1074\/jbc.M112.370791","article-title":"Molecular and biological characterization of Streptococcal SpyA-mediated ADP-ribosylation of intermediate filament protein vimentin","volume":"287","author":"Icenogle","year":"2012","journal-title":"J Biol Chem"},{"key":"10.1016\/j.therap.2025.02.012_bib0305","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1016\/j.tim.2019.07.001","article-title":"How BspC from Streptococcus agalactiae interacts with host vimentin during meningitis","volume":"27","author":"Beninati","year":"2019","journal-title":"Trends Microbiol"},{"key":"10.1016\/j.therap.2025.02.012_bib0310","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1186\/s13567-023-01135-3","article-title":"Vimentin affects inflammation and neutrophil recruitment in airway epithelium during Streptococcus suis serotype 2\u00a0infection","volume":"54","author":"Meng","year":"2023","journal-title":"Vet Res"},{"key":"10.1016\/j.therap.2025.02.012_bib0315","doi-asserted-by":"crossref","first-page":"e0172486","DOI":"10.1371\/journal.pone.0172486","article-title":"Effects of delayed NSAID administration after experimental eccentric contraction injury\u00a0\u2013\u00a0a cellular and proteomics study","volume":"12","author":"Bryant","year":"2017","journal-title":"PLoS One"},{"key":"10.1016\/j.therap.2025.02.012_bib0320","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1016\/j.jmii.2011.04.012","article-title":"Ibuprofen worsens Streptococcus pyogenes soft tissue infections in mice","volume":"44","author":"Weng","year":"2011","journal-title":"J Microbiol Immunol Infect"},{"key":"10.1016\/j.therap.2025.02.012_bib0325","doi-asserted-by":"crossref","first-page":"1429","DOI":"10.1093\/infdis\/jit594","article-title":"Effects of selective and nonselective nonsteroidal anti-inflammatory drugs on antibiotic efficacy of experimental group A streptococcal myonecrosis","volume":"209","author":"Hamilton","year":"2014","journal-title":"J Infect Dis"},{"key":"10.1016\/j.therap.2025.02.012_bib0165","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1111\/fcp.12336","article-title":"The role of nonsteroidal anti-inflammatory drugs intramuscular injection in the development and severity of deep soft tissue infection in mice","volume":"32","author":"Ture","year":"2018","journal-title":"Fundam Clin Pharmacol"}],"container-title":["Therapies"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S004059572500040X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S004059572500040X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,8,5]],"date-time":"2025-08-05T16:06:55Z","timestamp":1754410015000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S004059572500040X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7]]},"references-count":33,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2025,7]]}},"alternative-id":["S004059572500040X"],"URL":"https:\/\/doi.org\/10.1016\/j.therap.2025.02.012","relation":{},"ISSN":["0040-5957"],"issn-type":[{"value":"0040-5957","type":"print"}],"subject":[],"published":{"date-parts":[[2025,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Impact d\u00e9l\u00e9t\u00e8re d\u2019un anti-inflammatoire non st\u00e9ro\u00efdien pris pour fi\u00e8vre ou douleur aigu\u00eb en cas d\u2019infection streptococcique","name":"articletitle","label":"Article Title"},{"value":"Therapies","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.therap.2025.02.012","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Soci\u00e9t\u00e9 fran\u00e7aise de pharmacologie et de th\u00e9rapeutique. Published by Elsevier Masson SAS. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}